| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.20e-09 | 37 | 181 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.51e-09 | 38 | 181 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.56e-08 | 11 | 181 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.04e-07 | 130 | 181 | 10 | GO:0005200 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 KRT12 MYOM1 MAP1A SYNM SPTA1 SPTAN1 SPTB SPTBN1 SPTBN2 OBSCN ERVK-7 ERVK-21 ERVK-9 ERVK-10 PPL ACTL7B MRPS10 KRT222 ERVK-8 ERVK-19 EIF3A DMD ERVK-24 | 1.82e-06 | 891 | 181 | 24 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 6.09e-06 | 14 | 181 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.99e-05 | 37 | 181 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.46e-05 | 21 | 181 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 5.87e-05 | 46 | 181 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 8.17e-05 | 2 | 181 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 8.17e-05 | 2 | 181 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 WAPL ATRX CHD9 CHD8 ERVK-7 ERVK-10 HMCES ERVK-8 ASCC3 | 1.44e-04 | 262 | 181 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | actin filament binding | 2.34e-04 | 227 | 181 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.58e-04 | 230 | 181 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 3.79e-04 | 38 | 181 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | zinc ion binding | UBA5 ERVK-6 ZMYND11 SLC4A8 KDM4C TRPS1 ZDBF2 ERVK-7 ERVK-21 IDE ERVK-9 ERVK-10 GTF2H2 LTN1 ERVK-8 ERVK-19 MME DMD ERVK-24 | 4.84e-04 | 891 | 181 | 19 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | UBA5 ERVK-6 ZMYND11 SLC4A8 KDM4C EGLN1 TRPS1 ZDBF2 ERVK-7 ERVK-21 IDE ERVK-9 ERVK-10 GTF2H2 PIM1 LTN1 ERVK-8 ERVK-19 MTARC2 MME DMD ERVK-24 MOCOS | 4.85e-04 | 1189 | 181 | 23 | GO:0046914 |
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA5 ABCC3 WAPL ATRX MYO5B KIF1B UBA2 CHD9 CHD8 IDE MYH14 MOV10L1 ASCC3 ACSM6 ABCG8 | 4.92e-04 | 614 | 181 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 5.97e-04 | 206 | 181 | 8 | GO:0140030 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 6.12e-04 | 43 | 181 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 7.59e-04 | 79 | 181 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.09e-03 | 339 | 181 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.11e-03 | 86 | 181 | 5 | GO:0035064 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.14e-03 | 23 | 181 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 1.20e-03 | 6 | 181 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | molybdenum ion binding | 1.20e-03 | 6 | 181 | 2 | GO:0030151 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.24e-03 | 88 | 181 | 5 | GO:0140034 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 IDE ERVK-9 ERVK-10 BLMH ERVK-8 ERVK-19 MME ERVK-24 | 1.94e-03 | 430 | 181 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | tRNA pseudouridine synthase activity | 2.21e-03 | 8 | 181 | 2 | GO:0106029 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 WAPL ATRX CHD9 CHD8 ERVK-7 ERVK-10 HMCES PUS10 NYNRIN MOV10L1 ERVK-8 PUS1 ASCC3 | 2.30e-03 | 645 | 181 | 14 | GO:0140640 |
| GeneOntologyBiologicalProcess | DNA integration | 4.51e-08 | 13 | 171 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 7.56e-07 | 89 | 171 | 8 | GO:1901880 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | UBA5 MICAL1 MAP1A SWAP70 SPTA1 SPTAN1 SPTB SPTBN1 SPTBN2 WNK1 TGFB2 WDR45 MID1IP1 LTN1 SUPT16H ASCC2 ASCC3 GCN1 FBXW7 | 9.42e-07 | 617 | 171 | 19 | GO:0022411 |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 1.23e-06 | 66 | 171 | 7 | GO:0030042 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.84e-06 | 100 | 171 | 8 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 2.67e-06 | 105 | 171 | 8 | GO:1901879 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 3.27e-06 | 144 | 171 | 9 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 3.27e-06 | 144 | 171 | 9 | GO:0043244 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 4.41e-06 | 52 | 171 | 6 | GO:0030835 | |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 1.13e-05 | 61 | 171 | 6 | GO:0030834 | |
| GeneOntologyBiologicalProcess | ribosome-associated ubiquitin-dependent protein catabolic process | 1.91e-05 | 7 | 171 | 3 | GO:1990116 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | MICAL1 MAP1A SWAP70 SPTA1 SPTAN1 SPTB SPTBN1 SPTBN2 WNK1 MID1IP1 SUPT16H | 3.27e-05 | 291 | 171 | 11 | GO:0032984 |
| GeneOntologyBiologicalProcess | actin filament capping | 3.85e-05 | 46 | 171 | 5 | GO:0051693 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 4.74e-05 | 48 | 171 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by integrin | 6.83e-05 | 2 | 171 | 2 | GO:0033633 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 7.57e-05 | 85 | 171 | 6 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 7.57e-05 | 85 | 171 | 6 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 9.78e-05 | 89 | 171 | 6 | GO:0006949 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion mediated by integrin | 1.17e-04 | 12 | 171 | 3 | GO:0033629 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 ILF3 ERVK-7 ERVK-21 IDE ERVK-9 ERVK-10 ERVK-8 ERVK-19 EIF3A ERVK-24 FUT8 STOM | 1.37e-04 | 464 | 171 | 13 | GO:0016032 |
| GeneOntologyBiologicalProcess | rescue of stalled ribosome | 1.74e-04 | 34 | 171 | 4 | GO:0072344 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 2.21e-04 | 194 | 171 | 8 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 2.45e-04 | 197 | 171 | 8 | GO:1902904 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 3.99e-04 | 75 | 171 | 5 | GO:0030837 | |
| GeneOntologyBiologicalProcess | ribosome disassembly | 3.99e-04 | 42 | 171 | 4 | GO:0032790 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 4.06e-04 | 4 | 171 | 2 | GO:0061789 | |
| GeneOntologyCellularComponent | spectrin | 4.37e-09 | 9 | 172 | 5 | GO:0008091 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 5.40e-07 | 9 | 172 | 4 | GO:0014731 | |
| GeneOntologyCellularComponent | cell cortex | UNC13B IQGAP2 MYO5B SPTA1 SPTAN1 SPTB SPTBN1 SPTBN2 TRIP10 RYR1 GUCY1B1 UNC13C | 6.07e-05 | 371 | 172 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | cuticular plate | 1.47e-04 | 13 | 172 | 3 | GO:0032437 | |
| GeneOntologyCellularComponent | activating signal cointegrator 1 complex | 2.01e-04 | 3 | 172 | 2 | GO:0099053 | |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 4.00e-04 | 4 | 172 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | cell cortex region | 5.07e-04 | 45 | 172 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | supramolecular fiber | MICAL1 KRT12 PDE4D MYOM1 MAP1A IQGAP2 SYNM SPTAN1 KIF1B SPTBN1 OBSCN TRIP10 RYR1 PPL CEP170 MID1IP1 MYH14 KRT222 EIF3A DMD NUDC | 7.10e-04 | 1179 | 172 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MICAL1 KRT12 PDE4D MYOM1 MAP1A IQGAP2 SYNM SPTAN1 KIF1B SPTBN1 OBSCN TRIP10 RYR1 PPL CEP170 MID1IP1 MYH14 KRT222 EIF3A DMD NUDC | 7.73e-04 | 1187 | 172 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 8.59e-04 | 23 | 172 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.03e-03 | 93 | 172 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | myosin filament | 1.10e-03 | 25 | 172 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber | 1.38e-03 | 7 | 172 | 2 | GO:0097457 | |
| Domain | Spectrin_repeat | 4.31e-09 | 29 | 162 | 7 | IPR002017 | |
| Domain | SPEC | 9.10e-09 | 32 | 162 | 7 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 9.10e-09 | 32 | 162 | 7 | IPR018159 | |
| Domain | Spectrin | 3.47e-08 | 23 | 162 | 6 | PF00435 | |
| Domain | Spectrin_bsu | 2.55e-06 | 4 | 162 | 3 | IPR016343 | |
| Domain | CH | 2.10e-05 | 65 | 162 | 6 | SM00033 | |
| Domain | ANION_EXCHANGER_2 | 2.19e-05 | 7 | 162 | 3 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 2.19e-05 | 7 | 162 | 3 | PS00219 | |
| Domain | CH | 3.22e-05 | 70 | 162 | 6 | PF00307 | |
| Domain | - | 3.49e-05 | 71 | 162 | 6 | 1.10.418.10 | |
| Domain | CH | 4.09e-05 | 73 | 162 | 6 | PS50021 | |
| Domain | ACTININ_2 | 4.25e-05 | 23 | 162 | 4 | PS00020 | |
| Domain | ACTININ_1 | 4.25e-05 | 23 | 162 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.25e-05 | 23 | 162 | 4 | IPR001589 | |
| Domain | CH-domain | 4.77e-05 | 75 | 162 | 6 | IPR001715 | |
| Domain | HTH_MYB | 5.18e-05 | 9 | 162 | 3 | PS51294 | |
| Domain | - | 5.18e-05 | 9 | 162 | 3 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 5.18e-05 | 9 | 162 | 3 | IPR013769 | |
| Domain | Band_3_cyto | 5.18e-05 | 9 | 162 | 3 | PF07565 | |
| Domain | Myb_dom | 5.18e-05 | 9 | 162 | 3 | IPR017930 | |
| Domain | PTrfase/Anion_transptr | 7.35e-05 | 10 | 162 | 3 | IPR016152 | |
| Domain | HCO3_transpt_euk | 7.35e-05 | 10 | 162 | 3 | IPR003020 | |
| Domain | HCO3_cotransp | 7.35e-05 | 10 | 162 | 3 | PF00955 | |
| Domain | HCO3_transpt_C | 7.35e-05 | 10 | 162 | 3 | IPR011531 | |
| Domain | MOSC | 2.23e-04 | 3 | 162 | 2 | PF03473 | |
| Domain | MOSC_N | 2.23e-04 | 3 | 162 | 2 | PF03476 | |
| Domain | Cmyb_C | 2.23e-04 | 3 | 162 | 2 | PF09316 | |
| Domain | Unc-13 | 2.23e-04 | 3 | 162 | 2 | IPR027080 | |
| Domain | MOSC | 2.23e-04 | 3 | 162 | 2 | PS51340 | |
| Domain | C-myb_C | 2.23e-04 | 3 | 162 | 2 | IPR015395 | |
| Domain | MOSC_N | 2.23e-04 | 3 | 162 | 2 | IPR005303 | |
| Domain | MoCF_Sase_C | 2.23e-04 | 3 | 162 | 2 | IPR005302 | |
| Domain | Munc13_dom-2 | 7.35e-04 | 5 | 162 | 2 | IPR014772 | |
| Domain | MHD2 | 7.35e-04 | 5 | 162 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 7.35e-04 | 5 | 162 | 2 | IPR019558 | |
| Domain | Na/HCO3_transpt | 7.35e-04 | 5 | 162 | 2 | IPR003024 | |
| Domain | Pyrv_Knase-like_insert_dom | 7.35e-04 | 5 | 162 | 2 | IPR011037 | |
| Domain | INTEGRASE | 7.35e-04 | 5 | 162 | 2 | PS50994 | |
| Domain | Integrase_cat-core | 7.35e-04 | 5 | 162 | 2 | IPR001584 | |
| Domain | Membr_traf_MHD | 7.35e-04 | 5 | 162 | 2 | PF10540 | |
| Domain | DUF1041 | 7.35e-04 | 5 | 162 | 2 | SM01145 | |
| Domain | EPHD | 8.74e-04 | 22 | 162 | 3 | PS51805 | |
| Domain | SANT | 9.21e-04 | 50 | 162 | 4 | SM00717 | |
| Domain | TUDOR | 9.99e-04 | 23 | 162 | 3 | PS50304 | |
| Domain | SANT/Myb | 1.07e-03 | 52 | 162 | 4 | IPR001005 | |
| Domain | - | 1.10e-03 | 6 | 162 | 2 | 2.40.50.90 | |
| Domain | BRK | 1.10e-03 | 6 | 162 | 2 | SM00592 | |
| Domain | Staphylococal_nuclease_OB-fold | 1.10e-03 | 6 | 162 | 2 | IPR016071 | |
| Domain | BRK_domain | 1.10e-03 | 6 | 162 | 2 | IPR006576 | |
| Domain | EFhand_Ca_insen | 1.10e-03 | 6 | 162 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.10e-03 | 6 | 162 | 2 | IPR014837 | |
| Domain | BRK | 1.10e-03 | 6 | 162 | 2 | PF07533 | |
| Domain | ZF_PHD_2 | 1.43e-03 | 95 | 162 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 1.49e-03 | 96 | 162 | 5 | PS01359 | |
| Domain | Munc13_1 | 1.53e-03 | 7 | 162 | 2 | IPR014770 | |
| Domain | MHD1 | 1.53e-03 | 7 | 162 | 2 | PS51258 | |
| Domain | DUF1041 | 1.53e-03 | 7 | 162 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.53e-03 | 7 | 162 | 2 | IPR010439 | |
| Domain | TUDOR | 1.61e-03 | 27 | 162 | 3 | SM00333 | |
| Domain | Tudor | 2.19e-03 | 30 | 162 | 3 | IPR002999 | |
| Domain | PH_dom-spectrin-type | 2.59e-03 | 9 | 162 | 2 | IPR001605 | |
| Domain | SNF2_N | 2.64e-03 | 32 | 162 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.64e-03 | 32 | 162 | 3 | PF00176 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.13e-08 | 10 | 123 | 5 | MM15112 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 6.60e-06 | 31 | 123 | 5 | M877 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.86e-05 | 38 | 123 | 5 | MM14969 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 7.44e-05 | 10 | 123 | 3 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 7.44e-05 | 10 | 123 | 3 | MM15073 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 7.26e-10 | 4 | 182 | 4 | 10469592 | |
| Pubmed | 7.26e-10 | 4 | 182 | 4 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 7.26e-10 | 4 | 182 | 4 | 3862089 | |
| Pubmed | 7.26e-10 | 4 | 182 | 4 | 21412925 | ||
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 7.26e-10 | 4 | 182 | 4 | 12820899 | |
| Pubmed | UBA5 GRIPAP1 SWAP70 SYNM SPTAN1 SPTB KIF1B SPTBN1 UBA2 LDHA PPL EHD2 CEP170 ATIC CDC5L | 8.86e-10 | 360 | 182 | 15 | 33111431 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 9.16e-10 | 10 | 182 | 5 | 22159418 | |
| Pubmed | GRIPAP1 SLC4A8 SWAP70 MYO5B SYNM KDM4C MARK1 SPTBN2 CUL7 WNK1 CEP170 TTBK1 LTN1 EIF3A CDC5L MGA NEURL4 | 1.15e-09 | 493 | 182 | 17 | 15368895 | |
| Pubmed | SRRM1 SPAG1 KRT12 ILF3 GTPBP6 ATRX IQGAP2 MYO5B SPTA1 SPTAN1 SPTBN1 SPTBN2 NUCB2 RNF17 STK31 SLC4A3 PPL MYH14 SUPT16H RBM5 DLD UGGT2 DLST EIF3A DMD PLXNA2 PRRC2B RAI1 | 2.27e-09 | 1442 | 182 | 28 | 35575683 | |
| Pubmed | 2.86e-09 | 12 | 182 | 5 | 14557543 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.61e-09 | 5 | 182 | 4 | 12629516 | |
| Pubmed | UNC13B WAPL GTPBP6 ATRX SYNM KDM4C IFT172 SPTAN1 SPTB KIF1B SPTBN1 SPTBN2 TRPS1 CHD9 LRP1B CFAP298 SLC4A3 WDR19 TCERG1 GUCY1B1 MYH14 KRT222 DLST ATIC FUT8 SOS2 | 3.91e-09 | 1285 | 182 | 26 | 35914814 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | GRIPAP1 MYO5B MARK1 IDE CEP170 MYH14 CEP250 LTN1 ASCC2 UNK UGGT2 EIF3A ASCC3 FUT8 GCN1 NEURL4 PRRC2B STOM MOCOS | 1.94e-08 | 754 | 182 | 19 | 33060197 |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 3.01e-08 | 18 | 182 | 5 | 12119179 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ILF3 ATRX IFT172 SPTAN1 SPTBN1 ARHGEF12 CHD8 LDHA RABL6 TCERG1 DLD UNK CDC5L PHIP PRRC2B | 3.62e-08 | 475 | 182 | 15 | 31040226 |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.66e-08 | 94 | 182 | 8 | 21542922 | |
| Pubmed | ILF3 SPTAN1 SPTBN1 SPTBN2 PPIL4 PPAT LDHA CEP170 PUS1 RBM5 DLST EIF3A CDC5L MGA NUDC PRRC2B | 3.98e-08 | 551 | 182 | 16 | 34728620 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | UBA5 GRIPAP1 PDE4D SWAP70 SPTAN1 KIF1B SPTBN1 NUCB2 UBA2 IDE PPAT LDHA WNK1 TRIP10 AKT1S1 BLMH RABL6 PSMD6 MYH14 SUPT16H PUS1 DLD EIF3A ATIC NUDC GCN1 | 4.78e-08 | 1455 | 182 | 26 | 22863883 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBA5 SRRM1 SPAG1 GRIPAP1 SWAP70 KIF1B SPTBN1 SIN3A IDE LDHA WNK1 TRIP10 PPL BLMH CEP170 PSMD6 CFDP1 SUPT16H DLD DLST EIF3A ATIC NUDC GCN1 PRRC2B | 5.73e-08 | 1367 | 182 | 25 | 32687490 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SRRM1 ILF3 TCF20 MYO5B SPTBN2 CUL7 LDHA BLMH CEP170 PSMD6 MYH14 SUPT16H EIF3A ATIC CDC5L ASCC3 MGA NUDC GCN1 NEURL4 PHIP | 1.11e-07 | 1024 | 182 | 21 | 24711643 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | WAPL ILF3 ATRX SPTAN1 SPTBN1 PPIL4 IDE PPAT LDHA BLMH PSMD6 TCERG1 MYH14 PIM1 SUPT16H PUS1 RBM5 DLD DLST EIF3A ATIC CDC5L NUDC GCN1 PHIP | 1.26e-07 | 1425 | 182 | 25 | 30948266 |
| Pubmed | MICAL1 PDE4D ILF3 MAP1A IQGAP2 MYO5B MARK1 SPTA1 SPTAN1 SPTB KIF1B SPTBN1 SPTBN2 ARHGEF12 LDHA PNMA8B CEP170 PSMD6 MYH14 DLD DLST EIF3A DMD CDC5L PRRC2B | 1.36e-07 | 1431 | 182 | 25 | 37142655 | |
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 8479293 | ||
| Pubmed | Developmental expression of brain beta-spectrin isoform messenger RNAs. | 1.41e-07 | 3 | 182 | 3 | 1467942 | |
| Pubmed | MYO5B SPTAN1 SPTBN1 SPTBN2 TRPS1 IDE CUL7 BLMH PSMD6 CLCN7 LTN1 SUPT16H PUS1 DMD CDC5L MAPK11 NUDC GCN1 NEURL4 PRRC2B FBXW7 | 1.66e-07 | 1049 | 182 | 21 | 27880917 | |
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.81e-07 | 25 | 182 | 5 | 8493579 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | SRRM1 PPIL4 UBA2 TACC2 SIN3A CEP170 MYH14 DPPA4 DLD TAF1L NEURL4 | 2.01e-07 | 269 | 182 | 11 | 29511261 |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 2.33e-07 | 11 | 182 | 4 | 17607528 | |
| Pubmed | WAPL TCF20 SWAP70 SPTAN1 SPTBN2 CHD8 SIN3A CEP170 TCERG1 CDC5L ASCC3 MGA NUDC GCN1 PRRC2B | 2.34e-07 | 549 | 182 | 15 | 38280479 | |
| Pubmed | TCF20 MAP1A SPTAN1 SPTBN1 SPTBN2 CHD8 WNK1 TCERG1 CEP250 EIF3A DMD MGA GCN1 SOS2 | 3.19e-07 | 486 | 182 | 14 | 20936779 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | WAPL ILF3 TCF20 ATRX PPIL4 CHD8 TCERG1 CFDP1 SUPT16H MGA TAF1L | 3.33e-07 | 283 | 182 | 11 | 30585729 |
| Pubmed | GRIPAP1 WAPL TCF20 EGLN1 NUCB2 ZDBF2 WNK1 HMCES CEP170 GUCY1B1 RBM5 UNK UGGT2 ATIC CDC5L MGA MYBL2 | 3.61e-07 | 733 | 182 | 17 | 34672954 | |
| Pubmed | SRRM1 TCF20 SPTAN1 SPTBN1 SPTBN2 CHD8 CUL7 CEP170 MYH14 DLD ATIC ASCC3 GCN1 PHIP PRRC2B RAI1 | 3.93e-07 | 653 | 182 | 16 | 22586326 | |
| Pubmed | 5.00e-07 | 13 | 182 | 4 | 18796539 | ||
| Pubmed | TCF20 ATRX SPTAN1 SPTBN1 TRPS1 PPIL4 CHD8 SIN3A CUL7 PSMD6 MRPS10 MID1IP1 TCERG1 MYH14 CFDP1 DLD UNK EIF3A MGA NUDC TAF1L PRRC2B MYBL2 FBXW7 | 5.05e-07 | 1429 | 182 | 24 | 35140242 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | WAPL ILF3 ATRX MAP1A EGLN1 TACC2 SIN3A LDHA WNK1 CEP170 TCERG1 CFDP1 DLD EIF3A ATIC CDC5L NUDC GCN1 PRRC2B | 5.26e-07 | 934 | 182 | 19 | 33916271 |
| Pubmed | Loss of β2-spectrin prevents cardiomyocyte differentiation and heart development. | 5.62e-07 | 4 | 182 | 3 | 24064296 | |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 7983737 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | GRIPAP1 ILF3 SWAP70 SPTAN1 SPTBN1 SPTBN2 UBA2 IDE PPAT LDHA WNK1 PSMD6 TCERG1 MYH14 CEP250 DLD EIF3A NUDC | 5.72e-07 | 847 | 182 | 18 | 35235311 |
| Pubmed | SRRM1 ILF3 ATRX SPTAN1 EGLN1 PPIL4 LDHA CEP170 TCERG1 MYH14 EIF3A CDC5L MGA | 6.59e-07 | 441 | 182 | 13 | 31239290 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SRRM1 ZMYND11 WAPL TCF20 ATRX CHD9 CHD8 SIN3A FSIP2 CFDP1 SUPT16H MGA PHIP RAI1 MYBL2 | 8.45e-07 | 608 | 182 | 15 | 36089195 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SRRM1 IFT172 PPIL4 UBA2 IDE PPL PSMD6 LTN1 PUS1 DLD EIF3A DMD CDC5L ASCC3 MAPK11 FUT8 NUDC GCN1 PRRC2B | 9.82e-07 | 974 | 182 | 19 | 28675297 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SRRM1 WAPL TCF20 ATRX SPTAN1 SPTBN1 CHD9 CHD8 SIN3A SUPT16H CDC5L RAI1 | 1.28e-06 | 394 | 182 | 12 | 27248496 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | PDE4D MAP1A MARK1 SPTB SPTBN2 IDE LDHA RYR1 PPL CEP170 MYH14 RBM5 DLST GCN1 PRRC2B STOM | 1.74e-06 | 732 | 182 | 16 | 34732716 |
| Pubmed | SRRM1 ZMYND11 WAPL ILF3 TCF20 ATRX TRPS1 PPIL4 UBA2 CHD9 CHD8 SIN3A EHD2 TCERG1 CFDP1 SUPT16H EIF3A ATIC CDC5L | 1.77e-06 | 1014 | 182 | 19 | 32416067 | |
| Pubmed | 1.81e-06 | 156 | 182 | 8 | 37108203 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPAG1 SWAP70 SPTAN1 SPTBN1 SPTBN2 ARHGEF12 LDHA NLRP2 PPL CANT1 PALM3 ATIC NUDC GCN1 | 1.89e-06 | 565 | 182 | 14 | 25468996 |
| Pubmed | 2.10e-06 | 18 | 182 | 4 | 18664271 | ||
| Pubmed | MYOM1 SPTB KIF1B SPTBN1 OBSCN WNK1 RYR1 CEP170 MYH14 SUPT16H RBM5 EIF3A MGA | 2.47e-06 | 497 | 182 | 13 | 23414517 | |
| Pubmed | ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors. | 2.79e-06 | 6 | 182 | 3 | 37069398 | |
| Pubmed | 2.79e-06 | 6 | 182 | 3 | 15063128 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | SRRM1 ILF3 IQGAP2 SPTAN1 SPTBN1 SPTBN2 UBA2 LDHA BLMH CEP170 PSMD6 MRPS10 TCERG1 SUPT16H EIF3A ATIC CDC5L ASCC3 NUDC GCN1 | 2.85e-06 | 1149 | 182 | 20 | 35446349 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | GRIPAP1 ATRX MAP1A KIF1B UBA2 TACC2 ZDBF2 CUL7 WNK1 TCERG1 DLD UNK PRRC2B MYBL2 | 2.99e-06 | 588 | 182 | 14 | 38580884 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRRM1 WAPL ILF3 TCF20 ATRX PPIL4 CHD8 ZDBF2 LDHA CEP170 TCERG1 SUPT16H CDC5L MGA TAF1L PHIP RAI1 MYBL2 | 3.06e-06 | 954 | 182 | 18 | 36373674 |
| Pubmed | UNC13B SRRM1 ILF3 IQGAP2 SPTAN1 SPTBN1 SPTBN2 PPIL4 LDHA CEP170 MRPS10 GTF2H2 TCERG1 MYH14 SUPT16H ASCC2 RBM5 DLST ASCC3 GCN1 PRRC2B STOM | 3.28e-06 | 1371 | 182 | 22 | 36244648 | |
| Pubmed | 3.29e-06 | 20 | 182 | 4 | 18723693 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.46e-06 | 120 | 182 | 7 | 31413325 | |
| Pubmed | SRRM1 ILF3 ATRX SYNM SPTAN1 SPTBN1 SPTBN2 NUCB2 WDR19 FAM204A MRPS10 CLCN7 SUPT16H ASCC2 DLD UGGT2 DLST CDC5L ASCC3 NUDC NEURL4 VPS13B STOM | 3.54e-06 | 1487 | 182 | 23 | 33957083 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | SRRM1 SPTAN1 SPTBN1 PPAT LDHA PPL MYH14 SUPT16H DLD DLST EIF3A ATIC GCN1 STOM | 4.31e-06 | 607 | 182 | 14 | 39147351 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ILF3 MAP1A CHD8 TACC2 HMCES BLMH CEP170 TCERG1 MYH14 CDC5L MGA NUDC | 4.36e-06 | 444 | 182 | 12 | 34795231 |
| Pubmed | 4.37e-06 | 234 | 182 | 9 | 36243803 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 3186715 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ILF3 SPTA1 SPTAN1 SPTBN1 MUC19 CHD8 LDHA RYR1 PSMD6 MYH14 MOV10L1 DLD EIF3A ATIC GCN1 STOM | 6.00e-06 | 807 | 182 | 16 | 30575818 |
| Pubmed | SRRM1 ZMYND11 WAPL MAP1A TRPS1 CHD9 CHD8 SIN3A CUL7 CEP170 MCTP1 LTN1 SUPT16H TRAF3IP3 ASCC3 MGA PHIP PRRC2B RAI1 | 7.01e-06 | 1116 | 182 | 19 | 31753913 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ILF3 MAP1A SWAP70 SPTAN1 EGLN1 PPIL4 CEP170 PSMD6 MYH14 ASCC2 UNK ASCC3 MGA GCN1 PRRC2B | 7.05e-06 | 724 | 182 | 15 | 36232890 |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 7.18e-06 | 134 | 182 | 7 | 25452129 | |
| Pubmed | UBA5 ILF3 IFT172 SPTAN1 SPTBN1 SIN3A PSMD6 TCERG1 SUPT16H EIF3A CDC5L ASCC3 NUDC GCN1 | 7.57e-06 | 638 | 182 | 14 | 33239621 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | WAPL ILF3 TCF20 SPTAN1 SPTBN1 PPIL4 CHD8 LDHA BLMH TCERG1 MYH14 LTN1 SUPT16H DLST EIF3A ATIC CDC5L ASCC3 MGA GCN1 PHIP | 9.23e-06 | 1353 | 182 | 21 | 29467282 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | WAPL PDE4D ILF3 TRPS1 TACC2 IDE PPL BLMH CEP170 EIF3A CDC5L NUDC GCN1 NEURL4 VPS13B PRRC2B STOM MYBL1 MYBL2 | 1.13e-05 | 1155 | 182 | 19 | 20360068 |
| Pubmed | SRRM1 ILF3 SPTAN1 SPTBN1 SPTBN2 OBSCN LDHA PSMD6 MYH14 SUPT16H | 1.16e-05 | 334 | 182 | 10 | 30425250 | |
| Pubmed | ILF3 SPTAN1 SPTBN1 CHD9 LDHA PSMD6 MYH14 SUPT16H EIF3A CDC5L NUDC GCN1 | 1.27e-05 | 494 | 182 | 12 | 26831064 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SRRM1 ILF3 GTPBP6 SYNM EGLN1 TACC2 ZDBF2 IDE CUL7 PPAT PSMD6 MRPS10 SUPT16H PUS1 DLST MTARC2 NUDC NEURL4 PHIP VPS13B PRRC2B STOM | 1.29e-05 | 1496 | 182 | 22 | 32877691 |
| Pubmed | ILF3 SLC4A8 TCF20 IQGAP2 SPTAN1 SPTBN1 SPTBN2 ARHGEF12 CHD8 CEP170 WDR45 SUPT16H CDC5L MGA NEURL4 PRRC2B RAI1 | 1.38e-05 | 963 | 182 | 17 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRM1 WAPL ILF3 TCF20 ATRX SPTAN1 KIF1B SPTBN1 UBA2 SIN3A AKT1S1 PPL UNK MOCOS MYBL2 | 1.55e-05 | 774 | 182 | 15 | 15302935 |
| Pubmed | A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. | 1.65e-05 | 10 | 182 | 3 | 18548008 | |
| Pubmed | 1.65e-05 | 10 | 182 | 3 | 12970426 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SRRM1 ILF3 TCF20 MAP1A MARK1 SPTAN1 SPTBN1 SPTBN2 PPIL4 CHD9 LDHA CEP170 TCERG1 SUPT16H RBM5 DLST CDC5L GCN1 | 1.68e-05 | 1082 | 182 | 18 | 38697112 |
| Pubmed | 1.93e-05 | 156 | 182 | 7 | 22952844 | ||
| Pubmed | 1.98e-05 | 105 | 182 | 6 | 9628581 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SRRM1 WAPL ILF3 UBA2 CHD8 LDHA RABL6 MRPS10 GTF2H2 TCERG1 SUPT16H PUS1 DLD EIF3A CDC5L ASCC3 NUDC GCN1 PHIP STOM | 2.11e-05 | 1318 | 182 | 20 | 30463901 |
| Pubmed | ILF3 TCF20 UBA2 CHD9 CHD8 SIN3A PPAT LDHA BLMH CEP170 PSMD6 TCERG1 RBM5 ATIC NUDC PRRC2B RAI1 MYBL2 | 2.17e-05 | 1103 | 182 | 18 | 34189442 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SPAG1 GRIPAP1 ATRX IQGAP2 MYO5B IFT172 KIF1B WNK1 AKT1S1 WDR19 CEP170 PSMD6 CCDC154 SUPT16H UGGT2 NUDC GCN1 NEURL4 PRRC2B STOM | 2.18e-05 | 1321 | 182 | 20 | 27173435 |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 2.26e-05 | 11 | 182 | 3 | 34767769 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 2.32e-05 | 221 | 182 | 8 | 29991511 | |
| Pubmed | SRRM1 IQGAP2 SPTAN1 SPTBN1 SPTBN2 LDHA EHD2 CEP170 PSMD6 MRPS10 MID1IP1 LTN1 SUPT16H ASCC2 DLST EIF3A CDC5L ASCC3 NUDC GCN1 PRRC2B | 2.33e-05 | 1440 | 182 | 21 | 30833792 | |
| Pubmed | 2.40e-05 | 222 | 182 | 8 | 35941108 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 2.45e-05 | 109 | 182 | 6 | 33554859 | |
| Pubmed | ILF3 KIF1B SPTBN1 CHD9 LDHA CEP170 PSMD6 DLD DLST EIF3A DMD CDC5L ASCC3 NUDC GCN1 | 2.57e-05 | 809 | 182 | 15 | 32129710 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | IQGAP2 MYO5B SPTBN1 ARHGEF12 LDHA TRIP10 RYR1 PPL EHD2 BLMH MYH14 CEP250 ROBO2 ATIC MME BCAM STOM | 2.71e-05 | 1016 | 182 | 17 | 19056867 |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 25096571 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 10852813 | ||
| Pubmed | A novel brain-specific isoform of beta spectrin: isolation and its interaction with Munc13. | 2.72e-05 | 2 | 182 | 2 | 9704016 | |
| Pubmed | Cellular response to small molecules that selectively stall protein synthesis by the ribosome. | 2.72e-05 | 2 | 182 | 2 | 30875366 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 1391962 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 12652298 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 19606063 | ||
| Pubmed | Chaperone activity and prodan binding at the self-associating domain of erythroid spectrin. | 2.72e-05 | 2 | 182 | 2 | 15492010 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 8102379 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 9414314 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 24193021 | ||
| Interaction | ANK1 interactions | 4.23e-07 | 56 | 169 | 7 | int:ANK1 | |
| Interaction | SOX2 interactions | PDE4D ILF3 TCF20 MAP1A MARK1 SPTAN1 SPTB SPTBN1 SPTBN2 TRPS1 CHD9 CHD8 ZDBF2 SIN3A IDE CUL7 LDHA RYR1 PPL CEP170 MYH14 SUPT16H RBM5 DLST ASCC3 GCN1 PRRC2B STOM MYBL2 | 7.11e-06 | 1422 | 169 | 29 | int:SOX2 |
| Interaction | HDAC4 interactions | SRRM1 GRIPAP1 ILF3 ATRX IFT172 SPTAN1 SPTBN1 CHD8 SIN3A CUL7 RABL6 TCERG1 DLD UNK CDC5L NUDC PHIP PRRC2B FOXP3 | 1.63e-05 | 744 | 169 | 19 | int:HDAC4 |
| Interaction | CALM1 interactions | UNC13B ATRX IQGAP2 MYO5B TRPC3 KIF1B OBSCN ARHGEF12 CUL7 WNK1 HMCES RYR1 BLMH UNK DLST CDC5L STOM | 2.15e-05 | 626 | 169 | 17 | int:CALM1 |
| Interaction | LINC02370 interactions | 3.15e-05 | 8 | 169 | 3 | int:LINC02370 | |
| Interaction | CBX3 interactions | SRRM1 WAPL TCF20 ATRX UBA2 CHD9 CHD8 CUL7 PIM1 CFDP1 SUPT16H UNK MGA PHIP HSD17B8 PRRC2B MYBL2 | 3.20e-05 | 646 | 169 | 17 | int:CBX3 |
| Interaction | CSNK2A2 interactions | SRRM1 TCF20 ATRX SYNM KIF1B PPIL4 SIN3A AKT1S1 CEP170 CFDP1 SUPT16H RBM5 PALM3 EIF3A CDC5L MGA GCN1 FBXW7 | 3.51e-05 | 718 | 169 | 18 | int:CSNK2A2 |
| Interaction | PML interactions | ILF3 ATRX MAP1A SPTA1 CHD8 TACC2 SIN3A LDHA HMCES BLMH CEP170 TCERG1 MYH14 DLST EIF3A CDC5L MAPK11 NUDC GCN1 PHIP FBXW7 | 3.71e-05 | 933 | 169 | 21 | int:PML |
| Interaction | SMC3 interactions | SRRM1 WAPL ATRX ARHGEF12 CUL7 CEP170 CFDP1 DLD CDC5L MGA GCN1 NEURL4 FOXP3 | 4.20e-05 | 408 | 169 | 13 | int:SMC3 |
| Interaction | KDM1A interactions | GRIPAP1 TCF20 KDM4C TRPS1 UBA2 CHD8 ZDBF2 SIN3A FAM204A MID1IP1 KRT222 SUPT16H ASCC2 UNK CDC5L ASCC3 MGA GCN1 MYBL2 FBXW7 FOXP3 | 4.20e-05 | 941 | 169 | 21 | int:KDM1A |
| Interaction | CDC14A interactions | 4.21e-05 | 111 | 169 | 7 | int:CDC14A | |
| Interaction | YAP1 interactions | WAPL TCF20 SWAP70 SPTAN1 SPTBN1 EGLN1 SPTBN2 UBA2 CHD8 SIN3A LDHA CEP170 PSMD6 TCERG1 MYH14 SUPT16H DLD UNK EIF3A MGA NUDC GCN1 FBXW7 | 4.51e-05 | 1095 | 169 | 23 | int:YAP1 |
| Interaction | WWTR1 interactions | WAPL TCF20 SWAP70 SPTAN1 CHD8 SIN3A CEP170 TCERG1 CDC5L ASCC3 NUDC GCN1 PRRC2B | 5.93e-05 | 422 | 169 | 13 | int:WWTR1 |
| Interaction | H2AC4 interactions | SRRM1 MICAL1 TCF20 ATRX SPTAN1 SPTBN1 CHD9 CHD8 IDE CFDP1 SUPT16H DLD DLST RAI1 | 9.69e-05 | 506 | 169 | 14 | int:H2AC4 |
| Interaction | USP7 interactions | SRRM1 ILF3 TCF20 ATRX SPTAN1 SPTBN1 TRPS1 PPIL4 ZDBF2 STK31 PPL BLMH WDR45 NYNRIN CEP250 SUPT16H DLST VWA3B DMD CDC5L SPDYE4 SLC4A5 PHIP VPS13B FOXP3 | 1.00e-04 | 1313 | 169 | 25 | int:USP7 |
| Interaction | EPB41L3 interactions | 1.03e-04 | 272 | 169 | 10 | int:EPB41L3 | |
| Interaction | XRCC6 interactions | WAPL ILF3 TCF20 ATRX SWAP70 SPTA1 SPTBN1 PPIL4 CHD8 CUL7 LDHA PSMD6 TCERG1 CFDP1 SUPT16H DLD DLST MGA NUDC TAF1L | 1.04e-04 | 928 | 169 | 20 | int:XRCC6 |
| Interaction | PRPF19 interactions | SRRM1 ZDBF2 CUL7 CEP250 KRT222 LTN1 RBM5 DLD DLST CDC5L NUDC GCN1 FBXW7 | 1.13e-04 | 450 | 169 | 13 | int:PRPF19 |
| Interaction | GATAD2A interactions | 1.18e-04 | 224 | 169 | 9 | int:GATAD2A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 SPDYE12 SPDYE11 SPDYE13 SPDYE15 SPDYE8 SPDYE14 | 1.62e-06 | 271 | 183 | 9 | chr7q11 |
| Cytoband | 1q41 | 1.45e-04 | 66 | 183 | 4 | 1q41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q41 | 5.41e-04 | 93 | 183 | 4 | chr1q41 | |
| Cytoband | 7q11.23 | 6.34e-04 | 97 | 183 | 4 | 7q11.23 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.02e-10 | 7 | 101 | 5 | 1113 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 3.59e-05 | 12 | 101 | 3 | 756 | |
| GeneFamily | UNC13 homologs | 1.84e-04 | 4 | 101 | 2 | 836 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.18e-04 | 53 | 101 | 4 | 532 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.05e-03 | 206 | 101 | 6 | 682 | |
| GeneFamily | Tudor domain containing | 1.15e-03 | 37 | 101 | 3 | 780 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.35e-03 | 10 | 101 | 2 | 100 | |
| GeneFamily | EF-hand domain containing | 1.44e-03 | 219 | 101 | 6 | 863 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.64e-03 | 11 | 101 | 2 | 1168 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.90e-03 | 51 | 101 | 3 | 870 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 3.24e-03 | 53 | 101 | 3 | 103 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.00e-03 | 66 | 101 | 3 | 722 | |
| GeneFamily | Zinc fingers MYND-type | 6.05e-03 | 21 | 101 | 2 | 87 | |
| Coexpression | ALFANO_MYC_TARGETS | 3.91e-06 | 239 | 170 | 10 | M2477 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | SRRM1 ZMYND11 ILF3 ATRX IQGAP2 SPTA1 SPTBN2 UBA2 IDE PPAT BLMH TCERG1 GUCY1B1 PIM1 CFDP1 SUPT16H PUS1 RBM5 DLD PIP5K1B EIF3A ATIC CDC5L NUDC SOS2 | 4.11e-06 | 1399 | 170 | 25 | M535 |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | PDE4D ILF3 ATRX MAP1A KIF1B TACC2 CHGA LDHA LRP1B SLC4A3 PSMD6 MRPS10 TCERG1 GUCY1B1 LTN1 DLD PIP5K1B UGGT2 ATIC DMD CDC5L MGA FBXW7 | 6.31e-06 | 1248 | 170 | 23 | M17728 |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | UNC13B SPAG1 PDE4D SWAP70 IQGAP2 KIAA0513 MARK1 NUCB2 TACC2 TGFB2 CANT1 UGGT2 BCAM VPS13B STOM | 6.58e-06 | 583 | 170 | 15 | M17454 |
| Coexpression | GSE6875_TCONV_VS_FOXP3_KO_TREG_DN | 6.70e-06 | 200 | 170 | 9 | M6802 | |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 1.07e-05 | 161 | 170 | 8 | M11857 | |
| Coexpression | HUTTMANN_B_CLL_POOR_SURVIVAL_DN | 4.08e-05 | 59 | 170 | 5 | M12653 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZMYND11 WAPL ATRX SWAP70 KDM4C CHD9 TGFB2 CEP170 LTN1 EIF3A DMD ASCC3 FUT8 PHIP VPS13B MYBL1 SOS2 | 4.46e-05 | 856 | 170 | 17 | M4500 |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP | 4.58e-05 | 197 | 170 | 8 | M6902 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | SRRM1 ZMYND11 KRT12 ILF3 TCF20 MYO5B SPTBN1 CHD9 IDE RYR1 WDR45 EIF3A DMD MGA STOM | 4.66e-05 | 690 | 170 | 15 | M12224 |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 4.92e-05 | 199 | 170 | 8 | M9501 | |
| Coexpression | GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN | 4.92e-05 | 199 | 170 | 8 | M3107 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_UP | 5.09e-05 | 200 | 170 | 8 | M5054 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | WAPL ILF3 SPTA1 SPTB SPTBN2 ARHGEF12 PPAT CFAP298 PSMD6 MRPS10 TCERG1 GFOD2 CCDC34 SUPT16H DLD PIP5K1B EIF3A ATIC BCAM NUDC STOM | 8.02e-05 | 1271 | 170 | 21 | M39197 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 9.36e-05 | 162 | 170 | 7 | M45037 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | SRRM1 ZMYND11 KRT12 ILF3 TCF20 MYO5B SPTBN1 CHD9 IDE RYR1 WDR45 EIF3A DMD MGA STOM | 1.03e-04 | 741 | 170 | 15 | MM1037 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SRRM1 MGAM ATRX NEXMIF KIF1B SPTBN1 CHD9 CHD8 SIN3A RNF17 STK31 PNMA8B FAM204A DPPA4 PIM1 MOV10L1 RBM5 ROBO2 EIF3A MGA MYBL1 MYBL2 | 2.01e-07 | 806 | 161 | 22 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SRRM1 MGAM ATRX NEXMIF KIF1B SPTBN1 TRPS1 CHD9 CHD8 RNF17 STK31 PNMA8B FAM204A MID1IP1 DPPA4 RBM5 ROBO2 EIF3A MGA PLXNA2 MYBL1 | 7.97e-07 | 804 | 161 | 21 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | ILF3 ATRX IQGAP2 MARK1 KIF1B TRPS1 IDE GUCY1B1 SUPT16H MME ASCC3 GCN1 PHIP VPS13B | 8.99e-07 | 369 | 161 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | ILF3 IQGAP2 KIF1B TRPS1 IDE WNK1 TGFB2 ATIC MME ASCC3 GCN1 PHIP VPS13B PLXNA2 | 1.48e-06 | 385 | 161 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | SRRM1 MGAM ATRX KIF1B CHD8 RNF17 STK31 PNMA8B DPPA4 RBM5 ROBO2 EIF3A MGA MYBL1 | 2.53e-06 | 403 | 161 | 14 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | SRRM1 MGAM ATRX SPTBN1 TRPS1 CHD9 CHD8 PNMA8B TGFB2 RBM5 ROBO2 EIF3A MGA PLXNA2 | 2.75e-06 | 406 | 161 | 14 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | MGAM ATRX SPTBN1 CHD9 CHD8 RNF17 STK31 PNMA8B FAM204A DPPA4 RBM5 ROBO2 EIF3A MGA | 3.00e-06 | 409 | 161 | 14 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200 | 3.57e-06 | 159 | 161 | 9 | gudmap_developingGonad_e12.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | SRRM1 MGAM ATRX SPTA1 KIF1B CHD8 PNMA8B FAM204A DPPA4 RBM5 ROBO2 MGA PLXNA2 MYBL1 | 3.75e-06 | 417 | 161 | 14 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 4.16e-06 | 162 | 161 | 9 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | SRRM1 ATRX SYNM NEXMIF KIF1B SPTBN1 CHD8 RNF17 STK31 WNK1 PNMA8B FAM204A MID1IP1 MOV10L1 RBM5 UGGT2 EIF3A MGA MYBL1 | 7.30e-06 | 778 | 161 | 19 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | SRRM1 MGAM ATRX KIF1B SPTBN1 TRPS1 CHD9 PNMA8B TGFB2 RBM5 PLXNA2 | 1.03e-05 | 281 | 161 | 11 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SRRM1 MGAM ATRX SPTA1 KIF1B SPTBN1 CHD9 CHD8 PNMA8B CEP170 FAM204A DPPA4 CCDC34 RBM5 ROBO2 EIF3A MGA PLXNA2 MYBL1 | 1.40e-05 | 815 | 161 | 19 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.42e-05 | 41 | 161 | 5 | gudmap_developingGonad_P2_testes_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.64e-05 | 192 | 161 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SRRM1 MGAM ATRX SPTBN1 TRPS1 CHD9 CHD8 PNMA8B TGFB2 RBM5 ROBO2 MGA PLXNA2 | 1.67e-05 | 413 | 161 | 13 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | SRRM1 ATRX SYNM NEXMIF SPTBN1 CHD8 RNF17 STK31 WNK1 PNMA8B FAM204A MOV10L1 RBM5 UNC13C MGA MOCOS MYBL1 MYBL2 | 2.31e-05 | 770 | 161 | 18 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_200 | 2.46e-05 | 155 | 161 | 8 | gudmap_developingGonad_e16.5_ovary_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | ILF3 IQGAP2 MARK1 KIF1B TRPS1 TGFB2 GUCY1B1 MME GCN1 PLXNA2 PRRC2B | 2.73e-05 | 312 | 161 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | MICAL1 SLC4A8 TCF20 ATRX IFT172 ARHGEF12 WDR19 CEP250 MOV10L1 SUPT16H RBM5 PALM3 ROBO2 UGGT2 SPDYE4 PHIP PLXNA2 FBXW7 | 2.74e-05 | 780 | 161 | 18 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | ATRX SYNM NEXMIF SPTBN1 CHD8 RNF17 STK31 PNMA8B MOV10L1 RBM5 UNC13C MYBL1 | 3.37e-05 | 379 | 161 | 12 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | SRRM1 ATRX NEXMIF SPTA1 SPTBN1 CHD9 CHD8 RNF17 STK31 RYR1 PNMA8B FAM204A MOV10L1 RBM5 UGGT2 EIF3A MGA MYBL1 | 3.51e-05 | 795 | 161 | 18 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | SRRM1 ATRX KIF1B SPTBN1 CHD9 CHD8 PNMA8B CEP170 FAM204A RBM5 PLXNA2 | 3.74e-05 | 323 | 161 | 11 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 4.19e-05 | 167 | 161 | 8 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 5.16e-05 | 172 | 161 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | UNC13B PDE4D SLC4A8 ATRX MAP1A KIF1B TRPS1 CHD8 ZDBF2 MID1IP1 FBXO44 PIM1 CCDC34 SUPT16H PALM3 EFCC1 EIF3A BCAM DMD PHIP | 5.93e-05 | 986 | 161 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | UNC13B SLC4A8 ATRX MAP1A MYO5B EGLN1 ZDBF2 PPAT WDR19 TCERG1 GUCY1B1 CCDC34 MOV10L1 SUPT16H PALM3 EIF3A DMD PHIP MYBL1 FBXW7 | 6.19e-05 | 989 | 161 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.43e-05 | 284 | 161 | 10 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.73e-05 | 230 | 161 | 9 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 9.94e-05 | 61 | 161 | 5 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | UNC13B SRRM1 SLC4A8 ATRX MAP1A SPTAN1 KIF1B SPTBN2 CHD9 ZDBF2 GTF2H2 MYH14 PIM1 CCDC34 PALM3 EIF3A DMD MAPK11 FUT8 PHIP STOM MYBL1 MYBL2 SOS2 | 1.05e-04 | 1370 | 161 | 24 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SRRM1 MGAM ATRX KIF1B SPTBN1 TRPS1 CHD9 CHD8 PNMA8B TGFB2 FAM204A RBM5 ROBO2 EIF3A MGA PLXNA2 MYBL1 | 1.09e-04 | 790 | 161 | 17 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 1.20e-04 | 194 | 161 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | SRRM1 MGAM MYOM1 ATRX SPTBN1 TRPS1 CHD9 CHD8 PNMA8B TGFB2 FAM204A MID1IP1 RBM5 UNC13C EIF3A MGA MYBL1 | 1.21e-04 | 797 | 161 | 17 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SRRM1 MGAM ATRX KIF1B SPTBN1 TRPS1 CHD9 CHD8 PNMA8B TGFB2 FAM204A RBM5 ROBO2 EIF3A MGA PLXNA2 MYBL1 | 1.28e-04 | 801 | 161 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_200 | 1.32e-04 | 147 | 161 | 7 | gudmap_developingGonad_e18.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 1.35e-04 | 65 | 161 | 5 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 1.50e-04 | 150 | 161 | 7 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.56e-04 | 151 | 161 | 7 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | ATRX NEXMIF CHD8 RNF17 STK31 PNMA8B DPPA4 MOV10L1 RBM5 MGA MYBL1 | 1.66e-04 | 382 | 161 | 11 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_100 | 1.67e-04 | 68 | 161 | 5 | gudmap_developingGonad_e12.5_ovary_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | ATRX CHD8 RNF17 STK31 AKT1S1 RABL6 FAM204A TCERG1 GUCY1B1 DPPA4 NYNRIN RBM5 ROBO2 EIF3A MGA PHIP MYBL2 | 1.67e-04 | 819 | 161 | 17 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | ATRX NEXMIF SPTBN1 CHD8 RNF17 STK31 PNMA8B MOV10L1 RBM5 MGA MYBL1 | 1.86e-04 | 387 | 161 | 11 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_200 | 1.91e-04 | 156 | 161 | 7 | gudmap_developingGonad_e12.5_ovary_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SLC4A8 TCF20 ATRX ZDBF2 WDR19 TCERG1 CCDC34 CEP250 SUPT16H RBM5 PALM3 ROBO2 EIF3A DMD PHIP MYBL1 FBXW7 | 1.99e-04 | 831 | 161 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.06e-04 | 210 | 161 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_100 | 2.19e-04 | 72 | 161 | 5 | gudmap_developingGonad_e18.5_ovary_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.19e-04 | 330 | 161 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 2.32e-04 | 161 | 161 | 7 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.49e-04 | 74 | 161 | 5 | gudmap_developingGonad_e14.5_ testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.59e-04 | 275 | 161 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | MGAM ATRX SPTBN1 TRPS1 CHD9 CHD8 PNMA8B RBM5 EIF3A MGA MYBL1 | 2.69e-04 | 404 | 161 | 11 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.73e-04 | 277 | 161 | 9 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | ATRX CHD8 RNF17 STK31 AKT1S1 DPPA4 ROBO2 EIF3A MGA PHIP MYBL2 | 2.80e-04 | 406 | 161 | 11 | gudmap_developingGonad_e12.5_testes_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200 | 2.82e-04 | 76 | 161 | 5 | gudmap_developingGonad_e16.5_epididymis_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_100 | 2.82e-04 | 76 | 161 | 5 | gudmap_developingGonad_e12.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | ATRX NEXMIF KIF1B SPTBN1 CHD9 CHD8 RNF17 STK31 PNMA8B FAM204A DPPA4 MOV10L1 RBM5 EIF3A MGA MYBL1 | 2.82e-04 | 776 | 161 | 16 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | e10.5_MaxilArch_top-relative-expression-ranked_100 | 2.85e-04 | 42 | 161 | 4 | Facebase_ST1_e10.5_MaxilArch_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_100 | 3.21e-04 | 18 | 161 | 3 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.29e-04 | 225 | 161 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.38e-04 | 79 | 161 | 5 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_100 | 3.79e-04 | 19 | 161 | 3 | gudmap_developingGonad_P2_epididymis_100_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 3.85e-04 | 175 | 161 | 7 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | WAPL SWAP70 SPTBN2 MUC19 SIN3A IDE PPAT RNF17 STK31 HMCES CD2 DPPA4 MOV10L1 NUDC MYBL1 MYBL2 | 3.90e-04 | 799 | 161 | 16 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SRRM1 MGAM ATRX KIF1B SPTBN1 TRPS1 CHD9 CHD8 PNMA8B TGFB2 MID1IP1 RBM5 EIF3A MGA PLXNA2 MYBL1 | 3.90e-04 | 799 | 161 | 16 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | IQGAP2 NEXMIF TRPS1 ZDBF2 TGFB2 GUCY1B1 NYNRIN ROBO2 MME MYBL1 | 4.00e-04 | 356 | 161 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | ILF3 ATRX IQGAP2 MARK1 KIF1B TRPS1 IDE GUCY1B1 SUPT16H EIF3A MME ASCC3 GCN1 PHIP VPS13B PLXNA2 | 4.28e-04 | 806 | 161 | 16 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_200 | 4.44e-04 | 20 | 161 | 3 | gudmap_developingGonad_e16.5_ovary_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100 | 4.49e-04 | 84 | 161 | 5 | gudmap_developingGonad_e14.5_ epididymis_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | UNC13B SLC4A8 MAP1A MARK1 KIF1B NUCB2 CHD8 ZDBF2 MID1IP1 FBXO44 CCDC34 SUPT16H EIF3A DMD PHIP HSD17B8 STOM | 4.56e-04 | 893 | 161 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.65e-04 | 298 | 161 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_100 | 5.00e-04 | 86 | 161 | 5 | gudmap_developingGonad_e16.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#1_top-relative-expression-ranked_500 | 5.17e-04 | 49 | 161 | 4 | gudmap_developingGonad_e14.5_ testes_500_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SRRM1 WAPL SLC4A8 ATRX TRPS1 CHD9 ZDBF2 RABL6 GTF2H2 TCERG1 MYH14 CCDC34 SUPT16H EIF3A DMD CDC5L MAPK11 PHIP MYBL1 MYBL2 FBXW7 | 5.51e-04 | 1257 | 161 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_100 | 5.93e-04 | 22 | 161 | 3 | gudmap_developingGonad_e16.5_epididymis_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 6.04e-04 | 136 | 161 | 6 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.31e-04 | 311 | 161 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.43e-04 | 249 | 161 | 8 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SRRM1 WAPL SLC4A8 ATRX TRPS1 CHD9 ZDBF2 RABL6 GTF2H2 TCERG1 MYH14 CCDC34 SUPT16H PALM3 EIF3A DMD CDC5L MAPK11 SLC4A5 PHIP MYBL1 MYBL2 FBXW7 | 6.62e-04 | 1459 | 161 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.70e-04 | 192 | 161 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | ATRX NEXMIF SPTBN1 CHD8 RNF17 STK31 PNMA8B MOV10L1 RBM5 MYBL1 | 7.64e-04 | 387 | 161 | 10 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_200 | 7.70e-04 | 24 | 161 | 3 | gudmap_developingGonad_e14.5_ testes_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | GRIPAP1 SLC4A8 MAP1A MARK1 TRPC3 NUCB2 PPIL4 CHD8 ZDBF2 WDR19 DMD PLXNA2 HSD17B8 STOM | 7.77e-04 | 688 | 161 | 14 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.30e-04 | 259 | 161 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 8.66e-04 | 97 | 161 | 5 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 8.92e-04 | 395 | 161 | 10 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | WAPL SWAP70 SPTBN2 MUC19 SIN3A IDE PPAT RNF17 STK31 HMCES DPPA4 MOV10L1 NUDC MYBL1 MYBL2 | 9.08e-04 | 781 | 161 | 15 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_200 | 9.40e-04 | 148 | 161 | 6 | gudmap_developingGonad_e14.5_ ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200 | 9.79e-04 | 26 | 161 | 3 | gudmap_developingGonad_e18.5_ovary_200_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_100 | 9.79e-04 | 26 | 161 | 3 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SRRM1 ATRX ARHGEF12 UBA2 CHD9 WNK1 CEP170 CCDC34 PALM3 EIF3A DMD MGA PHIP | 1.04e-03 | 629 | 161 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.04e-03 | 207 | 161 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.04e-03 | 334 | 161 | 9 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.05e-03 | 59 | 161 | 4 | gudmap_developingGonad_e16.5_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 1.08e-03 | 152 | 161 | 6 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | WAPL SPTBN2 MUC19 SIN3A IDE PPAT RNF17 STK31 DPPA4 KRT222 MOV10L1 ATIC NUDC MYBL1 MYBL2 | 1.09e-03 | 795 | 161 | 15 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.11e-03 | 337 | 161 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.16e-03 | 339 | 161 | 9 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_500 | 1.16e-03 | 409 | 161 | 10 | gudmap_developingGonad_e16.5_testes_500 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | SRRM1 SYNM KDM4C MARK1 IFT172 EGLN1 OBSCN ZDBF2 LRP1B SLC4A3 WDR19 CLCN7 TCERG1 CCDC34 CEP250 LTN1 PIP5K1B PHIP PLXNA2 FBXW7 | 1.21e-03 | 1245 | 161 | 20 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 5.48e-08 | 189 | 172 | 9 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|Mesenchymal_cells / Lineage and Cell class | 6.11e-07 | 184 | 172 | 8 | 83987abaedc26e6da477bc70d65e10b1ab1aea60 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-07 | 190 | 172 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-Treg|ICU-SEP / Disease, condition lineage and cell class | 1.02e-06 | 197 | 172 | 8 | c3ee2d522fbfe67069ddba2d1abfc4f5ca230c26 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 6.31e-06 | 179 | 172 | 7 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.54e-06 | 180 | 172 | 7 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 7.29e-06 | 183 | 172 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | COVID-19_Severe-RBC|COVID-19_Severe / disease group, cell group and cell class | 7.55e-06 | 184 | 172 | 7 | bb58244194ffb5558fbe85c5f856888210dcb1e8 | |
| ToppCell | COVID-19_Severe-RBC|World / disease group, cell group and cell class | 7.82e-06 | 185 | 172 | 7 | 96b7058b1b282134970aa9e75285760a9f94a8b5 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.39e-06 | 187 | 172 | 7 | c4ba9dfedbcf0357a8627af03f4fe1770e985a03 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.39e-06 | 187 | 172 | 7 | 13023661c26aaf9e42262a4ff91f2fb26e8a3eaf | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 188 | 172 | 7 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.69e-06 | 188 | 172 | 7 | a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.69e-06 | 188 | 172 | 7 | adf9011ba8e3c6418fb68bf5c44b2e3b0ec7dafe | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 188 | 172 | 7 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.99e-06 | 189 | 172 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 9.31e-06 | 190 | 172 | 7 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.31e-06 | 190 | 172 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | severe_COVID-19-RBC|severe_COVID-19 / disease group, cell group and cell class (v2) | 9.31e-06 | 190 | 172 | 7 | 3a5723c2daf58c1932edd70910db4b8b30f63f42 | |
| ToppCell | severe_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 9.96e-06 | 192 | 172 | 7 | 1b4e28fd2e3d70ab48dbe96b280d35395889fbe2 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 193 | 172 | 7 | 54506c0da2f219f472b95e8935a78b657a8dec41 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 193 | 172 | 7 | 2d42721fac1bee294ede47d609bebb3e7d36bf0c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 194 | 172 | 7 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.07e-05 | 194 | 172 | 7 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-05 | 194 | 172 | 7 | ad3eb98f94a007c5988ede06238255f5b03bee6e | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-late_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-05 | 194 | 172 | 7 | 23b06707d21306b4483d64cb350b86aef352ce38 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-05 | 194 | 172 | 7 | a281ebab117589fc922ead0a712cfe0a844c94ac | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 195 | 172 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-05 | 196 | 172 | 7 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-05 | 196 | 172 | 7 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | COVID-CD4-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.18e-05 | 197 | 172 | 7 | 39ee4b93625c994813044d8dd8854fba2bd99940 | |
| ToppCell | Parenchymal-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 198 | 172 | 7 | 24b1138746dd69d1cda419f7070ef5a402d07563 | |
| ToppCell | Parenchymal-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 198 | 172 | 7 | 745e966fd52f06485061727cdbd9358b9df7d97d | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD8+_T_naive|Int-URO / Disease, condition lineage and cell class | 1.22e-05 | 198 | 172 | 7 | 8c7d00d8c27fb47954d8ac53eebc4582e92b970c | |
| ToppCell | Parenchymal-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 198 | 172 | 7 | 2a00648d3aa5843d9e924e054c5e973025f86e97 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-CD8+_T_naive|ICU-SEP / Disease, condition lineage and cell class | 1.26e-05 | 199 | 172 | 7 | ae5936ff37a333d66840dd1dfc59c4ce750625cd | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-05 | 199 | 172 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.26e-05 | 199 | 172 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.30e-05 | 200 | 172 | 7 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.30e-05 | 200 | 172 | 7 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.90e-05 | 142 | 172 | 6 | 77fd145c1c500d580f70ac4e54c3fd879ecf0ab3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.00e-05 | 162 | 172 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 163 | 172 | 6 | 66ecd544d7b52e61880b125bf39d1f406af6900a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.73e-05 | 167 | 172 | 6 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.73e-05 | 167 | 172 | 6 | eed22d1a17aab84dacb1a488528bae9389644cb9 | |
| ToppCell | ASK440-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.89e-05 | 168 | 172 | 6 | 127559d1a083c68cda9fce143afcc3eec168df17 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.06e-05 | 169 | 172 | 6 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-05 | 170 | 172 | 6 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-05 | 170 | 172 | 6 | 985c2d5962100fab0d95bee39f382ccbe799331e | |
| ToppCell | COVID-19-lung-RBC|lung / Disease (COVID-19 only), tissue and cell type | 5.40e-05 | 171 | 172 | 6 | 0e8d63c8fbccdda4f1ef00de00667a50464b104b | |
| ToppCell | COVID-19-lung-RBC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.14e-05 | 175 | 172 | 6 | 4c35292ad2ac712ba7516f27dd6eac6ba8fdd163 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.74e-05 | 178 | 172 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.74e-05 | 178 | 172 | 6 | a16857da9f2907c176213a326112a1b4cbd0e628 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.74e-05 | 178 | 172 | 6 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.74e-05 | 178 | 172 | 6 | 850fcd368c4478c57eaedc74544773ea220f41f3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-05 | 179 | 172 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-05 | 180 | 172 | 6 | b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.62e-05 | 182 | 172 | 6 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.62e-05 | 182 | 172 | 6 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.62e-05 | 182 | 172 | 6 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | HSPCs-Neutro_prog.|World / Lineage and Cell class | 7.62e-05 | 182 | 172 | 6 | f2512354b90f55bf4172c28084bf52cf79e41d8a | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 182 | 172 | 6 | 41f1749e2368397bca49143786da0423792f03bd | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 7.62e-05 | 182 | 172 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | remission-Platelet|remission / disease stage, cell group and cell class | 7.62e-05 | 182 | 172 | 6 | 65e2798aacd670cbc3a8c8e9d1a2f7768513bb70 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.62e-05 | 182 | 172 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.62e-05 | 182 | 172 | 6 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.62e-05 | 182 | 172 | 6 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 7.86e-05 | 183 | 172 | 6 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.86e-05 | 183 | 172 | 6 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 183 | 172 | 6 | 9e6c96ada930e8559246a270dfc69fb3cbb3bdf3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 184 | 172 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 184 | 172 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.10e-05 | 184 | 172 | 6 | 24cbe9f2461ea920954e44bf3b2c2a6a5d4debfb | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.10e-05 | 184 | 172 | 6 | 98079fd048a63b51bbdf3833b6f15bf0ae99ea90 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early|lymph-node_spleen / Manually curated celltypes from each tissue | 8.10e-05 | 184 | 172 | 6 | 10607d7d92edcbb92d992900086b90b307421cc3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 184 | 172 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Lung-1m-Epithelial-alveolar_epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.10e-05 | 184 | 172 | 6 | 86c1551c4f7c7d0c35c14852b01b1e602fa5092a | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.10e-05 | 184 | 172 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.34e-05 | 185 | 172 | 6 | 44ce50cb99df8ffc50eba311adcf688477618659 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 8.34e-05 | 185 | 172 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.34e-05 | 185 | 172 | 6 | 17542ccd52a821c9e99b1a7469e80502e764b3fd | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.34e-05 | 185 | 172 | 6 | d685a5a2e525db2eba449cfa1e5cd54eb36162a8 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.34e-05 | 185 | 172 | 6 | 5d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.34e-05 | 185 | 172 | 6 | 100b5afdf3c6ab07ffc493f7883f5a7b31c59184 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class | 8.34e-05 | 185 | 172 | 6 | 30f064ab7c3890e6f419a845276b145112e78f52 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.34e-05 | 185 | 172 | 6 | f3b1907c3b6f930bc161f46efce5e143babab507 | |
| ToppCell | COVID-CD4-CD8_1|COVID / Condition, Cell_class and T cell subcluster | 8.34e-05 | 185 | 172 | 6 | c634bb04a081ae3214b68f6e4a147db5b2b916ed | |
| ToppCell | COVID-19_Severe-Hematopoietic_R-RBC|COVID-19_Severe / Disease group, lineage and cell class | 8.34e-05 | 185 | 172 | 6 | 3ed6090b822c6d1d400a421236cddc7511743932 | |
| ToppCell | (5)_Pericytes-(50)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.59e-05 | 186 | 172 | 6 | 67b59defdd1ed3608229cc5e2a3b480d92312afa | |
| ToppCell | (5)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.59e-05 | 186 | 172 | 6 | acbca8cc048d87faf859b3e77bdb38d0a3dad71c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 186 | 172 | 6 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 8.59e-05 | 186 | 172 | 6 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.59e-05 | 186 | 172 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 8.85e-05 | 187 | 172 | 6 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.85e-05 | 187 | 172 | 6 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-05 | 187 | 172 | 6 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.85e-05 | 187 | 172 | 6 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 8.85e-05 | 187 | 172 | 6 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| Drug | ADPribulose | 2.53e-08 | 13 | 168 | 5 | CID000197570 | |
| Drug | dimethyl adipimidate | 7.57e-08 | 30 | 168 | 6 | CID000025738 | |
| Drug | plakin | 1.67e-07 | 82 | 168 | 8 | CID000018752 | |
| Drug | MAPS | MAP1A MARK1 SPTA1 SPTAN1 SPTB SPTBN1 SPTBN2 ACTL7B DLD SLC4A5 | 1.63e-06 | 191 | 168 | 10 | CID000066161 |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | MICAL1 MAP1A KIAA0513 SPTAN1 SPTB SPTBN1 WNK1 TGFB2 CEP250 MAPK11 | 1.79e-06 | 193 | 168 | 10 | 4488_DN |
| Drug | PRODAN | 3.66e-06 | 15 | 168 | 4 | CID000028127 | |
| Drug | 6-propionyl-2-(dimethylamino)naphthalene | 4.86e-06 | 16 | 168 | 4 | CID000107729 | |
| Drug | Leupeptin hydrochloride | MGAM SPAG1 SPTA1 SPTAN1 SPTB SPTBN1 SPTBN2 IDE CHGA BLMH MME | 6.85e-06 | 276 | 168 | 11 | CID000003910 |
| Drug | im b | 8.07e-06 | 18 | 168 | 4 | CID000405731 | |
| Drug | AC1NDTNH | TRPS1 UBA2 PPAT NLRP2 RYR1 CFDP1 SUPT16H UNK ATIC MME TAF1L HSD17B8 | 9.74e-06 | 343 | 168 | 12 | CID004631409 |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.51e-05 | 195 | 168 | 9 | 3778_DN | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.51e-05 | 195 | 168 | 9 | 6101_DN | |
| Drug | Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.57e-05 | 196 | 168 | 9 | 4685_UP | |
| Drug | AC1L1HCM | 1.89e-05 | 22 | 168 | 4 | CID000004072 | |
| Drug | 2-nitro-5-thiocyanobenzoic acid | 2.73e-05 | 48 | 168 | 5 | CID000092266 | |
| Drug | N-ethylmaleimide | UNC13B ERVK-6 MYO5B SPTA1 SPTAN1 KIF1B SPTBN1 SPTBN2 IDE WNK1 ACTL7B BLMH MYH14 DLD | 2.76e-05 | 511 | 168 | 14 | CID000004362 |
| Drug | phenylhydrazine | 3.25e-05 | 82 | 168 | 6 | CID000007516 | |
| Disease | Intellectual Disability | UBA5 ZMYND11 TCF20 CHD8 SIN3A SLC6A3 RABL6 SUPT16H PUS1 ATIC ASCC3 FUT8 PHIP RAI1 | 1.69e-07 | 447 | 160 | 14 | C3714756 |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 6.23e-07 | 4 | 160 | 3 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.08e-06 | 34 | 160 | 5 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.08e-06 | 34 | 160 | 5 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.08e-06 | 34 | 160 | 5 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.08e-06 | 34 | 160 | 5 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.08e-06 | 34 | 160 | 5 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.08e-06 | 34 | 160 | 5 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.25e-06 | 35 | 160 | 5 | C0752122 | |
| Disease | osteochondrodysplasia (biomarker_via_orthology) | 2.92e-05 | 2 | 160 | 2 | DOID:2256 (biomarker_via_orthology) | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 5.91e-05 | 39 | 160 | 4 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | anemia (implicated_via_orthology) | 6.79e-05 | 15 | 160 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 1.15e-04 | 139 | 160 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.15e-04 | 139 | 160 | 6 | C0025363 | |
| Disease | Mental deficiency | 1.15e-04 | 139 | 160 | 6 | C0917816 | |
| Disease | Pheochromocytoma | 1.42e-04 | 19 | 160 | 3 | C0031511 | |
| Disease | Hereditary elliptocytosis | 1.74e-04 | 4 | 160 | 2 | cv:C0013902 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.87e-04 | 152 | 160 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | spermatogenic failure (is_implicated_in) | 2.56e-04 | 23 | 160 | 3 | DOID:0111910 (is_implicated_in) | |
| Disease | hereditary spherocytosis (is_implicated_in) | 2.89e-04 | 5 | 160 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 2.89e-04 | 5 | 160 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 2.89e-04 | 5 | 160 | 2 | C0221409 | |
| Disease | mean arterial pressure | GRIPAP1 TCF20 SWAP70 ARHGEF12 PPL CEP170 TTBK1 GUCY1B1 DLST PHIP | 4.16e-04 | 499 | 160 | 10 | EFO_0006340 |
| Disease | necrotizing enterocolitis | 4.16e-04 | 27 | 160 | 3 | EFO_0003928 | |
| Disease | Elliptocytosis, Hereditary | 4.32e-04 | 6 | 160 | 2 | C0013902 | |
| Disease | Prostatic Neoplasms | PDE4D NUCB2 LRP1B PPL MYH14 FBXO44 ROBO2 EIF3A MME MGA TAF1L | 5.66e-04 | 616 | 160 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | PDE4D NUCB2 LRP1B PPL MYH14 FBXO44 ROBO2 EIF3A MME MGA TAF1L | 5.66e-04 | 616 | 160 | 11 | C0376358 |
| Disease | CHARGE syndrome (implicated_via_orthology) | 6.03e-04 | 7 | 160 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Amphetamine-Related Disorders | 7.50e-04 | 75 | 160 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 7.50e-04 | 75 | 160 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 7.50e-04 | 75 | 160 | 4 | C0236804 | |
| Disease | Malignant neoplasm of breast | MICAL1 SPTAN1 OBSCN TACC2 WNK1 SLC6A3 CD2 PIM1 PUS1 MME DMD VPS13B HSD17B8 FBXW7 FOXP3 | 7.78e-04 | 1074 | 160 | 15 | C0006142 |
| Disease | Hereditary spherocytosis | 8.01e-04 | 8 | 160 | 2 | C0037889 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 8.01e-04 | 8 | 160 | 2 | EFO_0020829 | |
| Disease | lysophosphatidylethanolamine 18:1 measurement | 8.28e-04 | 34 | 160 | 3 | EFO_0010368 | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 1.03e-03 | 9 | 160 | 2 | DOID:12700 (biomarker_via_orthology) | |
| Disease | breast carcinoma | PDE4D ILF3 KDM4C KIF1B SPTBN2 TRPS1 ARHGEF12 TACC2 SIN3A SPDYE12 SLC6A3 TTBK1 DMD PHIP | 1.36e-03 | 1019 | 160 | 14 | EFO_0000305 |
| Disease | mean reticulocyte volume | SWAP70 IQGAP2 KDM4C NEXMIF SPTA1 TRPC3 SPTB SPDYE12 PIM1 NYNRIN PUS1 TRAF3IP3 | 1.43e-03 | 799 | 160 | 12 | EFO_0010701 |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 1.54e-03 | 42 | 160 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | Jeune thoracic dystrophy | 1.56e-03 | 11 | 160 | 2 | C0265275 | |
| Disease | Craniofacial Abnormalities | 1.65e-03 | 156 | 160 | 5 | C0376634 | |
| Disease | cholesterol in medium VLDL measurement | 1.76e-03 | 44 | 160 | 3 | EFO_0022225 | |
| Disease | Abnormality of the dentition | 1.86e-03 | 12 | 160 | 2 | HP_0000164 | |
| Disease | Ischemic stroke | 2.01e-03 | 324 | 160 | 7 | HP_0002140 | |
| Disease | total lipids in small LDL | 2.13e-03 | 47 | 160 | 3 | EFO_0022168 | |
| Disease | Adenoid Cystic Carcinoma | 2.18e-03 | 100 | 160 | 4 | C0010606 | |
| Disease | amygdala volume | 2.19e-03 | 13 | 160 | 2 | EFO_0006934 | |
| Disease | Bell's palsy | 2.34e-03 | 102 | 160 | 4 | EFO_0007167 | |
| Disease | phospholipids in medium LDL measurement | 2.40e-03 | 49 | 160 | 3 | EFO_0022183 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 2.40e-03 | 49 | 160 | 3 | EFO_0021897 | |
| Disease | cholesterol in medium LDL measurement | 2.40e-03 | 49 | 160 | 3 | EFO_0022224 | |
| Disease | phospholipids in IDL measurement | 2.85e-03 | 52 | 160 | 3 | EFO_0022164 | |
| Disease | total lipids in medium LDL | 2.85e-03 | 52 | 160 | 3 | EFO_0022180 | |
| Disease | total lipids in LDL measurement | 2.85e-03 | 52 | 160 | 3 | EFO_0022308 | |
| Disease | remnant cholesterol measurement | 2.88e-03 | 108 | 160 | 4 | EFO_0010815 | |
| Disease | mental or behavioural disorder | 2.99e-03 | 179 | 160 | 5 | EFO_0000677 | |
| Disease | forced expiratory volume, response to bronchodilator | 3.06e-03 | 445 | 160 | 8 | EFO_0004314, GO_0097366 | |
| Disease | Small cell carcinoma of lung | 3.17e-03 | 54 | 160 | 3 | C0149925 | |
| Disease | T-Cell Lymphoma | 3.34e-03 | 16 | 160 | 2 | C0079772 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 3.34e-03 | 16 | 160 | 2 | C1257877 | |
| Disease | free cholesterol measurement | 3.39e-03 | 113 | 160 | 4 | EFO_0008591 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 3.77e-03 | 17 | 160 | 2 | cv:C0270914 | |
| Disease | phospholipids in LDL measurement | 3.88e-03 | 58 | 160 | 3 | EFO_0022294 | |
| Disease | phospholipids in small LDL measurement | 4.07e-03 | 59 | 160 | 3 | EFO_0022297 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.30e-03 | 195 | 160 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | free cholesterol in VLDL measurement | 4.47e-03 | 61 | 160 | 3 | EFO_0022276 | |
| Disease | Hydrops Fetalis | 4.70e-03 | 19 | 160 | 2 | C0020305 | |
| Disease | Colorectal Carcinoma | UNC13B ABCC3 SPTBN2 OBSCN WNK1 PUS10 TRAF3IP3 DMD PHIP FBXW7 | 5.11e-03 | 702 | 160 | 10 | C0009402 |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 5.34e-03 | 65 | 160 | 3 | DOID:0080208 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVSAKGEEDKWSFER | 76 | Q6P461 | |
| LWERTEEDSKSIKSD | 346 | Q5SW79 | |
| RGESSEAVPEKTWKE | 46 | Q5RGS3 | |
| KFEEDVEEETERWGK | 346 | P48751 | |
| WGFKEKRTEARSSDE | 191 | Q96B36 | |
| WELKEDVDEGKIREF | 761 | Q9HCK8 | |
| PSIKKTEWSREEEEK | 56 | Q99459 | |
| LWVSKEEFEERGSVA | 396 | Q9Y614 | |
| SDDIDDIKWEKTSDK | 51 | P06729 | |
| SAWEGVDRRKATDAK | 401 | Q9H1I8 | |
| EGSDDEAEWVVTKDK | 436 | Q9NZN4 | |
| GKEWTSTEKSREEDQ | 16 | Q7L190 | |
| EKVRDLDDFLWKAET | 351 | Q9H221 | |
| EFEEIEGRWKKLSSQ | 1021 | P11532 | |
| VDIETLEKTEKVDWS | 201 | Q9BYV7 | |
| LAEEKAWDAKGRLEE | 336 | A6NI56 | |
| AKTEWEGAERKSLED | 431 | A6NI56 | |
| KSGLEKRIDQAVEEW | 151 | Q9H8W3 | |
| EERWQEEKKTPAAEA | 401 | Q9HA90 | |
| TEWPTEREKVKKAAD | 951 | Q9NZN5 | |
| EKAKEFIIGTGWEEA | 56 | Q6P387 | |
| SKVLRSDAAWEDKDE | 26 | Q9BUV8 | |
| KEEVEEVLDSKAGWG | 901 | Q7Z5J4 | |
| DDIVKVEVWDVVDKG | 91 | Q3YEC7 | |
| EEKDLWSLKEEDRSQ | 236 | O15438 | |
| EEEESCWEKQKSEKR | 421 | Q8WUA2 | |
| GGEETWEAEKRKAEE | 386 | A6NDB9 | |
| TRGDAGEEEEKREKW | 326 | O60268 | |
| EEEARLKKSADTLWG | 311 | P00338 | |
| SWEAKADTEKDEKTA | 466 | O94822 | |
| SVEAKERTLEEWKEL | 326 | Q15759 | |
| EDEIDDSVGRIEKAW | 666 | Q9NZR2 | |
| TEEEKDTWEEKKQRE | 616 | P78559 | |
| GVIDITAWDKDAGKR | 531 | Q6DN14 | |
| KAIRVEAVSDKWEDD | 91 | Q9BXT6 | |
| EEGSAWKSKDILVDL | 116 | Q9NPA3 | |
| AEAWFIEKSGELRKE | 316 | Q99456 | |
| EKGAVWTVDELEFRK | 401 | Q9BZS1 | |
| DLEDDSDKLQEKSWK | 1296 | Q8IWI9 | |
| DSVEARKVEKPGWEA | 1351 | Q6PRD1 | |
| ELEGNSGRWEEKEEK | 116 | O95050 | |
| SGRWEEKEEKLRAAV | 121 | O95050 | |
| KKELEAAWGVEVFDR | 186 | O43824 | |
| EKGSELHWKDVRELV | 1301 | O60333 | |
| ERDEKEEKVSWAGIG | 1801 | Q6ZU64 | |
| TVEWSIKIRDEEKID | 951 | O43451 | |
| RKEAEEASQKEIEEW | 271 | Q5HYC2 | |
| WIVEKGIKDVETEDL | 186 | O95786 | |
| GREKEKAWEIQEATF | 3521 | Q5CZC0 | |
| LSDSGDKVAVEWDKD | 136 | Q8WVQ1 | |
| DKVAVEWDKDHGVLE | 141 | Q8WVQ1 | |
| KKVSWSGRDRDDEEA | 6 | P51798 | |
| DRLTAEIWKDVEGIV | 631 | Q7Z406 | |
| QDEDITTKIEGDWKR | 1566 | O75051 | |
| TEKVDEVIKEWEGSF | 221 | Q8N1A0 | |
| WGISDEKGLEVSKAD | 211 | Q7Z5P9 | |
| DSGVEEAWKIRKELD | 886 | O60437 | |
| EDVLAKELEDVNKWG | 391 | Q08499 | |
| EWKDEKRDLLTEGQS | 431 | O14986 | |
| SSVEVKEDKCWEKVE | 831 | Q14999 | |
| GDEWKVEDLSRDQRK | 101 | Q9H4M3 | |
| LREKVDKDEWISGAA | 526 | P08473 | |
| GLAEEVKSRWEKEQL | 121 | Q8WVF5 | |
| ARWETKLDEVVTSEG | 666 | Q9H3R0 | |
| KRWAEGAESLEVLAE | 421 | Q8TDZ2 | |
| INGKRAFEEEKWDEI | 781 | Q96EN8 | |
| LEEESWRTKAGSVEL | 1506 | Q92616 | |
| VWEDIKKEAQLDEEG | 21 | Q02153 | |
| TLEKEEEEDRDGHTW | 516 | Q9NX02 | |
| KDQLKEVWEETDGLD | 226 | P80303 | |
| VERLESEEEKLADWK | 631 | P52756 | |
| DAFIEGEEWNKAKRV | 1366 | Q9UG01 | |
| SVRWFKDGKLLEEDD | 5156 | Q5VST9 | |
| DVRWEKAVGDTVAED | 86 | P36957 | |
| WIIDGERKLESSVEE | 306 | Q3MIT2 | |
| EIIDKSRKEGDTEAW | 266 | P87889 | |
| EIIDKSRKEGDTEAW | 266 | Q9YNA8 | |
| EIIDKSRKEGDTEAW | 266 | P62683 | |
| EIIDKSRKEGDTEAW | 266 | P63145 | |
| EIIDKSRKEGDTEAW | 266 | Q7LDI9 | |
| EIIDKSRKEGDTEAW | 266 | P63130 | |
| EIIDKSRKEGDTEAW | 266 | P62685 | |
| EIIDKSRKEGDTEAW | 266 | P63126 | |
| EIIDKSRKEGDTEAW | 266 | P62684 | |
| TDDQIEELKLKDEWG | 66 | P57076 | |
| WQEGLKDDEKLEVSE | 1641 | P46100 | |
| KEEEELTEEERKAAW | 2261 | P46100 | |
| EDSTWELKEDVDLAK | 806 | Q3L8U1 | |
| GSEDARKKKEDELWA | 101 | Q9UEE9 | |
| EVWFIGKEKEERDRL | 146 | Q96HJ3 | |
| EREGEKEKASWRAEK | 1346 | Q14152 | |
| SEDDWDKVIAVNLKG | 116 | Q92506 | |
| EDVEKLTVDWSRARD | 136 | Q9BV73 | |
| SDDGTVKLWDLKTGE | 641 | Q969H0 | |
| ALKAVSDWIDEQEKG | 41 | Q12906 | |
| EALWGKTEEEAKQLA | 31 | Q3B7J2 | |
| WKKETEELRAEDAEQ | 11 | Q8WW18 | |
| WVGKSEEQLKEEGIE | 401 | P09622 | |
| EKDDQDGAFTKWRVE | 381 | Q13867 | |
| DSSKDIRGDKITWIE | 246 | Q9GZT9 | |
| DTWDELLIGSVEVKK | 251 | Q969Z3 | |
| EETKEWKSEEELHRR | 466 | Q96JA4 | |
| EEWDKDVARKLGSTT | 451 | Q9P0L2 | |
| TEVAWTKDELKEALD | 691 | P14735 | |
| AKGWFERRLKEAEES | 521 | Q4V328 | |
| KTAEIEPKADGSWRE | 451 | P50895 | |
| WTIEKAREGEEEKTE | 2821 | P21817 | |
| AGLLEQWLKREKEEE | 331 | Q96FZ2 | |
| EVKKSSWTEEEDRII | 136 | P10243 | |
| FEVKVEELDEKWAGS | 956 | Q96JN8 | |
| TEKAKSLIEEGGDWD | 161 | Q15008 | |
| SLVRDAAGKEDIIEW | 191 | Q9P2P1 | |
| HVAGWTEDEETRKLK | 166 | Q6QHF9 | |
| RGESSEAVPEKTWKE | 46 | Q5TZK3 | |
| IKHVEKDRISDWGEL | 66 | P11309 | |
| AGDWREKEAKDLTEL | 176 | Q9BYC5 | |
| ERTWEILKEDESGSL | 16 | Q6P1K8 | |
| EPIWETLSEEKEESK | 186 | P82664 | |
| ELVGSVWTKEDKEIN | 801 | Q07890 | |
| VDWEEIGGLEDVKLK | 461 | Q9BVQ7 | |
| DSKEKASEERNLRWE | 526 | O15061 | |
| ESVLERSWGTEKVDV | 311 | Q9Y606 | |
| DVDKVTDTKPRVAEW | 346 | Q8IZX4 | |
| KESWLTGKEIEDIIE | 631 | Q13576 | |
| PEVKKSCWTEEEDRI | 131 | P10244 | |
| VDSLEGEKVNERKEW | 496 | Q5QGS0 | |
| VIESLGWSDEKDKRD | 356 | Q9ULN7 | |
| LGWKRKRECLDESDD | 56 | P0DUX0 | |
| LGWKRKRECLDESDD | 56 | P0DTA3 | |
| LGWKRKRECLDESDD | 56 | P0DUD1 | |
| WEREVLGIKRDKSDS | 926 | Q96ST3 | |
| EDGDIKRISTKEWAK | 231 | Q9UBT2 | |
| DEDKEAEGDLRRSWK | 731 | Q6ZUB1 | |
| EISVLIWDDAREGKD | 76 | Q9Y484 | |
| IWDDAREGKDSKEKL | 81 | Q9Y484 | |
| DWDKDGDVLAVIAEK | 61 | Q8NEZ3 | |
| KFEEDVEDGGERWSK | 141 | Q2Y0W8 | |
| SGKDWDELEEEARKA | 986 | Q9Y5B9 | |
| VKVEESSWLIEDGKV | 226 | Q9Y266 | |
| ATDAWGIKVERVEIK | 181 | P27105 | |
| EIIDKSRKEGDTEAW | 266 | P63128 | |
| EGWIREKEKILSSDD | 651 | Q01082 | |
| EKWDVVTRKSVGDVA | 586 | Q8N3C0 | |
| EQEEERLSKEWEDSK | 326 | P10645 | |
| EEDKGDGWTRVRRKE | 571 | Q15642 | |
| SNEGWEEEAKVEFLK | 586 | Q9BXT8 | |
| WKCDKREEFTSVRSE | 501 | Q9BXU1 | |
| DSKVVKTRAEGEWLS | 186 | P61812 | |
| EGTGKEKDWDLRDQL | 456 | Q9Y228 | |
| EEKDGLKEKVWTESS | 771 | Q9UHF7 | |
| EGVWDRDLEKSTRLE | 11 | Q8NFD4 | |
| EDFDSKEWVIIDKET | 536 | Q5TCY1 | |
| LIVKLEEDSWGSESK | 21 | P17040 | |
| KETRVSPEEAVKWGE | 71 | Q9NS28 | |
| RIKVRVWDEDDDIKS | 1281 | Q8NB66 | |
| QEEWRTAKGEEEIKT | 736 | Q8WWQ0 | |
| DWLDKVDKEGRELTL | 1331 | O15020 | |
| WESGSLLEREEKEKL | 931 | O14776 | |
| ERTWEILKEDESGSL | 16 | Q13888 | |
| WGIELVSEVSEEELK | 341 | Q9GZZ9 | |
| LGWKRKRECLDESDD | 56 | P0DUX1 | |
| LGWKRKRECLDESDD | 56 | A0A494C0Z2 | |
| LGWKRKRECLDESDD | 56 | P0DUD3 | |
| LGWKRKRECLDESDD | 56 | P0DUD4 | |
| LGWKRKRECLDESDD | 56 | P0DUD2 | |
| LKRKSEWSDESEEEL | 51 | A6NLX3 | |
| DWKSFQREEEEERKL | 81 | Q6ZQQ2 | |
| DVVESWIGEKENSLK | 1986 | Q13813 | |
| WITKRVTEILGFEDD | 51 | Q8IYB3 | |
| EAQDRETWGKKIDFL | 56 | Q01959 | |
| SFTAEEWEKIDGDIK | 86 | Q07617 | |
| DGDIKSWVSEIKKEE | 96 | Q07617 | |
| DINDKEKKTSETEGW | 216 | Q06203 | |
| ETVKEISLWKDEEVD | 1216 | Q9HCK1 | |
| SRDEDEEKLVASLWG | 836 | Q7Z5K2 | |
| DSADAKRTREEGKDW | 421 | Q5JSZ5 | |
| KRTREEGKDWAEAVG | 426 | Q5JSZ5 | |
| ESARWIKFEEKVEEG | 131 | Q9BY07 | |
| IKFEEKVEEGGERWS | 136 | Q9BY07 | |
| TIEWYKDGERVETDK | 61 | Q9HCK4 | |
| AEIITKEREVSEWKD | 2756 | O95359 | |
| RIKVRVWDEDDDIKS | 661 | O14795 | |
| KRETDDLEQWISEKE | 1696 | P11277 | |
| KKAENTGVELDDVWE | 1101 | P02549 | |
| TGTIGEDEDLIKWKA | 496 | P31939 | |
| EWRGSVDDKVKTETH | 1436 | Q9UGU0 | |
| EDDFEKLTWEISGGK | 771 | A0A1B0GTU1 | |
| RFWKSKNEDRGEEEA | 361 | Q15326 | |
| VKAKGDEDWSRDVCL | 2786 | Q7Z7G8 | |
| LGWKRKRECLDESDD | 56 | A0A494C191 | |
| FTEAELEEREKNWKE | 566 | Q9UH65 | |
| AEEWLDDKSSEKVTR | 816 | Q502W6 | |
| EEDDGEKIAIKLWLR | 491 | Q9H4A3 | |
| EDILTDEDEKTKGLW | 1196 | Q9NYU1 | |
| DEDEKTKGLWDSIKS | 1201 | Q9NYU1 | |
| DAWKKEAEEAGERAS | 676 | Q9C0B0 | |
| KCGELETKLDDDRVW | 426 | Q6NT04 | |
| EDDSDVEWKFARSKL | 666 | Q13507 | |
| VWRSAELTKDYKEGD | 21 | Q9ULV0 | |
| VVSWEESKDAKELVG | 756 | P52179 |